36
Participants
Start Date
September 6, 2023
Primary Completion Date
November 15, 2024
Study Completion Date
May 27, 2025
ART0380
Randomized patients will orally receive ART0380.
Memorial Sloan Kettering Cancer Center (MSKCC) - Memorial Hospital - Oncology, New York
Northwell Health R.J. Zuckerberg Cancer Center, Lake Success
Centre Francois Baclesse - Service d'Oncologie médicale, Caen
Western Pennsylvania Hospital, Pittsburgh
Hospital Universitario De Jaén, Jaén
Fundación Instituto Valenciano De Oncología, Valencia
Institut de Cancérologie de l'Ouest, Angers
Hopital Lyon Sud, Pierre-Bénite
University of Oklahoma/Sarah Cannon Research Institute, Oklahoma City
Hopital Cochin Saint Vincent De Paul, Paris
Centre Hospitalier Universitaire De Poitiers, Poitiers
University of California Los Angeles (UCLA), Los Angeles
The University of Chicago, Chicago
Dana Farber Cancer Center, Boston
Women and Infants Hospital, Providence
Lead Sponsor
Artios Pharma Ltd
INDUSTRY